HUP0003792A3 - Novel use of compounds for anti-pruritic activity - Google Patents

Novel use of compounds for anti-pruritic activity

Info

Publication number: HUP0003792A3
Authority: HU; Hungary
Prior art keywords: compounds; novel use; pruritic activity; pruritic; activity
Prior art date: 1997-10-17

Application number

HU0003792A

Other languages

Hungarian (hu)

Original Assignee

Smithkline Beecham Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-10-17

Filing date

1998-10-16

Publication date

2001-12-28

1998-10-16 Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp

2001-10-28 Publication of HUP0003792A2 publication Critical patent/HUP0003792A2/en

2001-12-28 Publication of HUP0003792A3 publication Critical patent/HUP0003792A3/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Dermatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

HU0003792A 1997-10-17 1998-10-16 Novel use of compounds for anti-pruritic activity HUP0003792A3 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US6374697P	1997-10-17	1997-10-17
PCT/US1998/021886 WO1999020280A1 (en)	1997-10-17	1998-10-16	Novel use of compounds for anti-pruritic activity

Publications (2)

Publication Number	Publication Date
HUP0003792A2 HUP0003792A2 (en)	2001-10-28
HUP0003792A3 true HUP0003792A3 (en)	2001-12-28

Family

ID=22051225

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HU0003792A HUP0003792A3 (en)	1997-10-17	1998-10-16	Novel use of compounds for anti-pruritic activity

Country Status (18)

Country	Link
EP (1)	EP1030666A4 (en)
JP (1)	JP2001520196A (en)
KR (1)	KR20010031149A (en)
CN (1)	CN1306426A (en)
AR (1)	AR015966A1 (en)
AU (1)	AU740875B2 (en)
BR (1)	BR9814080A (en)
CA (1)	CA2306985A1 (en)
CO (1)	CO4810374A1 (en)
CZ (1)	CZ20001376A3 (en)
HU (1)	HUP0003792A3 (en)
IL (1)	IL135581A0 (en)
NO (1)	NO20001847D0 (en)
NZ (1)	NZ503551A (en)
PL (1)	PL341062A1 (en)
TR (1)	TR200001040T2 (en)
WO (1)	WO1999020280A1 (en)
ZA (1)	ZA989450B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ526531A (en)	2001-01-31	2005-02-25	Pfizer Prod Inc	Ether derivatives useful as inhibitors of phosphodiesterase type IV (PDE4) isozymes
US7250518B2 (en)	2001-01-31	2007-07-31	Pfizer Inc.	Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes
CA2436551A1 (en)	2001-01-31	2002-08-08	Pfizer Products Inc.	Thiazolyl-, oxazolyl-, pyrrolyl-, and imidazolyl-acid amide derivatives useful as inhibitors of pde4 isozymes
EE200300360A (en)	2001-01-31	2003-12-15	Pfizer Products Inc.	Biaryl derivatives of nicotinamide used as inhibitors of PDE4 isozymes
US20030175314A1 (en) *	2001-11-19	2003-09-18	Didriksen Erik Johannes	Pharmaceutical composition for dermal application
US20060258703A1 (en) *	2003-07-17	2006-11-16	Ono Pharmaceutical Co., Ltd.	Remedy for pruritus comprising piperidine derivative as the active ingredient
WO2005053672A1 (en) *	2003-12-04	2005-06-16	Santen Pharmaceutical Co., Ltd.	Remedy for pruritus comprising cilomilast or salt thereof as the active ingredient
JP2005187458A (en) *	2003-12-04	2005-07-14	Santen Pharmaceut Co Ltd	Itchiness-treating agent consisting of cilomilast or its salt as active ingredient
BRPI0507604A (en) *	2004-02-14	2007-07-03	Smithkline Beecham Corp	medicines with hm74a receptor activity
JP2008137892A (en) *	2005-03-04	2008-06-19	Eisai Co Ltd	Antipruritic agent
PE20070405A1 (en)	2005-08-10	2007-05-06	Smithkline Beecham Corp	XANTHINE-DERIVED COMPOUNDS AS AGONISTS OF THE NICOTINIC ACID RECEPTOR HM74A
TWI404709B (en) *	2006-02-21	2013-08-11	Eisai R&D Man Co Ltd	4-(3-benzamidophenyl) -6,7-dimethoxy-2-methylamine quinazoline derivatives
CN101389612B (en) *	2006-02-21	2011-09-21	卫材R&D管理有限公司	Quinazoline derivatives
WO2008099887A1 (en)	2007-02-16	2008-08-21	Eisai R & D Management Co., Ltd.	Crystal, amorphous form and salt of methyl n-[3-(6,7-dimethoxy- 2-methylaminoquinazolin-4-yl)phenyl]terephthalamic acid
US8513269B2 (en)	2007-08-17	2013-08-20	Eisai R&D Management Co., Ltd.	Preparation for external use
AU2008290000B2 (en)	2007-08-17	2012-05-10	Eisai R & D Management Co., Ltd.	Method for producing quinazoline derivative
US20140121240A1 (en) *	2011-06-28	2014-05-01	Maruho Co., Ltd.	Novel pharmaceutical composition
JP6678685B2 (en)	2015-01-30	2020-04-08	上海珊▲頓▼医▲薬▼科技有限公司ＳｈａｎｔｏｎＰｈａｒｍａＣｏ．，Ｌｔｄ．	Prevention or treatment of uric or gouty diseases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0563168B1 (en) *	1990-12-21	2000-07-05	Beecham Group Plc	Xanthine derivatives
EP0889886B1 (en) *	1996-03-26	2002-09-18	ALTANA Pharma AG	Novel phenanthridines substituted in the 6 position
EP0912568B1 (en) *	1996-05-15	2002-11-20	ALTANA Pharma AG	imidazopyridines
ATE248167T1 (en) *	1997-03-07	2003-09-15	Altana Pharma Ag	TETRAZOLE DERIVATIVES
EP0998300A1 (en) *	1997-03-18	2000-05-10	Basf Aktiengesellschaft	Methods and compositions for modulating responsiveness to corticosteroids
WO1998055481A1 (en) *	1997-06-03	1998-12-10	Byk Gulden Lomberg Chemische Fabrik Gmbh	Benzonaphthyridine

1998
- 1998-10-15 AR ARP980105131A patent/AR015966A1/en not_active Application Discontinuation
- 1998-10-16 CZ CZ20001376A patent/CZ20001376A3/en unknown
- 1998-10-16 TR TR2000/01040T patent/TR200001040T2/en unknown
- 1998-10-16 HU HU0003792A patent/HUP0003792A3/en unknown
- 1998-10-16 NZ NZ503551A patent/NZ503551A/en unknown
- 1998-10-16 CN CN98810066A patent/CN1306426A/en active Pending
- 1998-10-16 ZA ZA989450A patent/ZA989450B/en unknown
- 1998-10-16 JP JP2000516677A patent/JP2001520196A/en not_active Withdrawn
- 1998-10-16 EP EP98953608A patent/EP1030666A4/en not_active Withdrawn
- 1998-10-16 AU AU10938/99A patent/AU740875B2/en not_active Ceased
- 1998-10-16 CO CO98060225A patent/CO4810374A1/en unknown
- 1998-10-16 BR BR9814080-9A patent/BR9814080A/en not_active IP Right Cessation
- 1998-10-16 IL IL13558198A patent/IL135581A0/en unknown
- 1998-10-16 CA CA002306985A patent/CA2306985A1/en not_active Abandoned
- 1998-10-16 KR KR1020007004053A patent/KR20010031149A/en not_active Withdrawn
- 1998-10-16 WO PCT/US1998/021886 patent/WO1999020280A1/en not_active Ceased
- 1998-10-16 PL PL98341062A patent/PL341062A1/en unknown
2000
- 2000-04-10 NO NO20001847A patent/NO20001847D0/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
CN1306426A (en)	2001-08-01
PL341062A1 (en)	2001-03-26
KR20010031149A (en)	2001-04-16
CZ20001376A3 (en)	2002-06-12
WO1999020280A1 (en)	1999-04-29
CO4810374A1 (en)	1999-06-30
NZ503551A (en)	2002-05-31
JP2001520196A (en)	2001-10-30
AU740875B2 (en)	2001-11-15
AR015966A1 (en)	2001-05-30
ZA989450B (en)	1999-04-19
BR9814080A (en)	2000-09-26
HUP0003792A2 (en)	2001-10-28
NO20001847L (en)	2000-04-10
EP1030666A1 (en)	2000-08-30
TR200001040T2 (en)	2001-01-22
CA2306985A1 (en)	1999-04-29
AU1093899A (en)	1999-05-10
IL135581A0 (en)	2001-05-20
EP1030666A4 (en)	2002-10-16
NO20001847D0 (en)	2000-04-10

Publication	Publication Date	Title
PL338259A1 (en)	2000-10-09	Novel spiroazabicyclic heterocyclic compounds
HUP0003792A3 (en)	2001-12-28	Novel use of compounds for anti-pruritic activity
EG24041A (en)	2008-04-03	New heterocyclic compounds
EG24412A (en)	2009-05-25	Novel compounds
PL340400A1 (en)	2001-01-29	2-phenyl-substituted imidazotriazinones as inhibitors of phosphodiesterase
CZ220099A3 (en)	1999-11-17	Novel compounds exhibiting analgetic activity
IL132170A0 (en)	2001-03-19	Novel heterocyclic compounds
PL338791A1 (en)	2000-11-20	Compounds exhibiting neuronic activity
IL125840A0 (en)	1999-04-11	Production of bromine compounds
IL113248A0 (en)	1995-07-31	Use of alpha - 1c specific compounds
PL327732A1 (en)	1998-12-21	Compounds of therapeutic activity
GB9701674D0 (en)	1997-03-19	Use of organic compounds
HU9800373D0 (en)	1998-04-28	Steroide compounds of anticeptive and antiosteoporosive activity
ZA981920B (en)	1998-09-07	Novel heterocyclic compounds
PL327538A1 (en)	1998-12-21	Novel compounds of analgesic activity
PL339673A1 (en)	2001-01-02	Novel compounds suitable for use as neuroprotective agents
ZA985448B (en)	1999-01-19	Novel heterocyclic compounds
HU9700442D0 (en)	1997-04-28	Compounds of pharmaceutical activity
ZA983800B (en)	1998-11-06	Novel heterocyclic compounds
AUPP059897A0 (en)	1998-01-08	New use of bicozamycin
GB9703492D0 (en)	1997-04-09	Novel compounds
GB9722026D0 (en)	1997-12-17	Use of compounds
SI1121108T1 (en)	2003-10-31	Novel therapeutic use of compounds with beta-3-agonist activity
ZA985449B (en)	1999-01-19	Novel heterocyclic compounds
GB9810855D0 (en)	1998-07-22	Use of compounds